The case for cost‐effectively treating cryoglobulinemic vasculitis with interferon‐free anti–hepatitis C virus therapy
Marcella Visentini, Stefania Colantuono, Guido Granata, Adriano de Santis, Massimo Fiorilli, Milvia Casato – 7 November 2014
Hepatic artery stenosis after liver transplantation: Is endovascular treatment always necessary?
Carlo Pulitano, David Joseph, Charbel Sandroussi, Deborah Verran, Simone I. Strasser, Nicholas A. Shackel, Geoffrey W. McCaughan, Michael Crawford – 6 November 2014 – Hepatic artery stenosis (HAS) is thought to predispose patients to biliary complications secondary to ischemic injury. Despite this, the clinical significance of HAS remains poorly defined. The aims of this study were to determine the prevalence and outcomes of HAS and to define which patients might benefit from endovascular treatment.
Is the Molecular Adsorbent Recirculating System the Answer for Children With Acute Liver Failure?
Philip Rosenthal – 6 November 2014
National survey of adult transplant hepatologists on the pediatric‐to‐adult care transition after liver transplantation
Madeleine R. Heldman, Min‐Woong Sohn, Elisa J. Gordon, Zeeshan Butt, Saeed Mohammed, Estella M. Alonso, Josh Levitsky – 6 November 2014 – Adult transplant hepatologists face challenges in providing care to young adults who received liver transplants during childhood. Because prior studies have focused mainly on pediatric providers, understanding these issues from the perspective of the adult hepatologist may provide novel insights and identify key barriers to care in this population.
Autosis occurs in the liver of patients with severe anorexia nervosa
Marouane Kheloufi, Chantal M. Boulanger, Patrice Codogno, Pierre‐Emmanuel Rautou – 5 November 2014
The clinical course of cirrhosis: The importance of multistate models and competing risks analysis
Peter Jepsen, Hendrik Vilstrup, Per Kragh Andersen – 5 November 2014 – Multistate models are models of disease progression that, for a patient group, define multiple outcome events, each of which may affect the time to develop another outcome event. Multistate models are highly relevant for studies of patients with cirrhosis; both the classical perception of cirrhosis as either compensated or decompensated and the recent, more complex models of cirrhosis progression are multistate models.
Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation
Parsia A. Vagefi, Jennifer L. Dodge, Francis Y. Yao, John P. Roberts – 5 November 2014 – A subset of liver transplantation (LT) recipients who undergo transplantation for hepatocellular carcinoma (HCC) will develop postoperative recurrence. There has yet to be a thorough investigation of donor factors influencing recurrence.
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation
Eleonora Terzi, W. Ray Kim, William Sanchez, Michael R. Charlton, Paul Schmeltzer, Gregory J. Gores, James C. Andrews, Thomas C. Smyrk, Julie K. Heimbach – 5 November 2014 – Transarterial chemoembolization (TACE) is a common treatment for patients with hepatocellular carcinoma (HCC) who are awaiting liver transplantation (LT). The aim of this study was to assess the impact of multiple TACE treatments on tumor necrosis, tumor recurrence, and survival in these patients.
Restoration of portal flow with a pericholedochal varix in adult living donor liver transplantation for patients with total portosplenomesenteric thrombosis
Ronald W. Busuttil, Jonathan R. Hiatt – 5 November 2014
Hemostatic status in liver transplantation: Association between preoperative procoagulants/anticoagulants and postoperative hemorrhaging/thrombosis
Nobuhisa Akamatsu, Yasuhiko Sugawara, Akiko Nakazawa, Yujiro Nishioka, Junichi Kaneko, Taku Aoki, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Norihiro Kokudo – 5 November 2014 – The delicate rebalanced hemostatic status of liver transplant recipients may lead to both hemorrhagic and thrombotic tendencies in this population. The aim of this study was to investigate the association between pretransplant procoagulants/anticoagulants and posttransplant bleeding and thrombosis among living donor liver transplant recipients.